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at any current frequency [4]. Linearity supports validity
of monitoring with only pre- and postdialysis measure-
ments.
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Reply from the Authors
We appreciate Piccoli’s interest in our article [1], and
thank him for further analysis of the data we presented.
We fully agree that a cyclical variation in BIA variables
was apparent in hemodialysis patients during both dialy-
sis and interdialysis periods according to the concept that
dialysis causes a reduction of total body water, and es-
pecially (or only) of extracellular body water, and that
total body water progressively increases between dialysis
sessions due to water retention.
Indeed, change in resistance, reactance, and phase an-
gle during a hemodialysis session can be affected by other
factors, such as an increase in hematocrit, variations in
electrolytes concentration, a rapid shift from intracellu-
lar to extracellular water, and others [2]. As a matter of
fact, acute changes in body water induced by dialysis are
not predicted well by data derived from BIA [3], and
when BIA was applied to estimate the fluid loss during
hemodialysis, overestimation usually occurred. As a con-
sequence, changes in BIA variables during either dialysis
or interdialysis periods are expected to reflect variation
in total body water and its extracellular/intracellular dis-
tribution, but also to be affected by other factors. Further
studies seem necessary to us to understand to which ex-
tent these data can be compared with those obtained in a
healthy population or in predialysis patients. In addition,
our results indicate that the measurement timing with re-
spect to dialysis session is a crucial aspect in assessing
BIA in such patients. Furthermore, since phase angle is
considered an independent marker of survival [ 4–6], the
point of time for performing the analysis may influence
the prognostic significance of such a parameter.
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End-stage renal disease
increases plasma
transcobalamin and neutralizes
influence of TCN 776C>G
polymorphism
To the Editor: A lack of influence of TCN 776C>G
has been recently reported on transcobalamin and ho-
mocysteine plasma levels in two series of patients with
kidney transplant and end-stage renal disease (ESRD),
contrary to what was previously observed in a healthy
population [1–3]. In the ESRD series, which included
66 hemodialysis patients, influences of MTHFR 677TT
(P = 0.024) and TCN 776CC (P = 0.036) on homocysteine
disappeared in a multivariate model that included a com-
bination of 677TTx776CC genotypes, a confounder of
each polymorphism [2]. The lack of influence of MTHFR
agreed with some of the previous data [4]. We performed
a similar study in 55 nonsupplemented hemodialysis pa-
tients. We confirmed the lack of influence of either TCN
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Table 1. Independent determinants of homocysteine and transcobalamin in 55 hemodialysis patients
95% P value P value
Dependent Independent Correlation confidence univariate multiple
determinant determinant coefficient interval regression regressiona
Homocysteine
Creatinine 0.448 0.249, 0.685 0.0002 <0.0001
Folate −0.462 −0.652, −0.216 0.0005 0.0005
Cholesterol 0.314 0.018, 0.559 0.0377 0.1268
Triglycerides 0.279 −0.019, 0.532 0.0664 0.1417
Albumin 0.213 −0.076, 0.469 0.1471 0.9518
Vitamin B12 −0.167 −0.418, 0.234 0.2342
C-reactive prot −0.142 −0.415, 0.155 0.3496
Transcobalamin 0.103 −0.184, 0.373 0.4841
ALAT 0.132 −0.416, 0.175 0.5562
Transcobalamin
ALAT 0.636 0.417, 0.784 <0.0001 <0.0001
Creatinine 0.190 −0.099, 0.450 0.1179 0.0609
Cholesterol −0.225 −0.486, 0.073 0.1380 0.0655
Albumin −0.123 −0.391, 0.164 0.4013
Folate −0.117 −0.383, 0.167 0.4197
Homocysteine 0.103 −0.184, 0.373 0.4841
C-reactive prot −0.083 −0.367, 0.216 0.5920
Vitamin B12 −0.076 −0.344, 0.204 0.5978
Triglycerides −0.032 −0.322, 0.264 0.8375
aThe multiple regression analysis included only the parameters that presented a P value lower than 0.2 in univariate analysis.
or MTHFR polymorphisms, and found a weak effect of
TCN 776G × MTHFR 677T allele combination on ho-
mocysteine (carriers vs. noncarriers 40.5 ± 11.3 vs. 30.9 ±
10.7 lmol/L, P = 0.0158). The single determi-
nant of plasma apo-transcobalamin was alanine-
aminotransferase, while creatinine was under the limit
of significance (Table 1). The level was higher in ESRD,
compared to 109 matched controls (719 ± 354 vs. 464 ±
160 pmol/L, P < 0.0001). ESRD increased plasma
transcobalamin by an unknown mechanism, possibly re-
lated to glomerular filtration and tubular uptake. Un-
der these conditions, the influence of TCN 776C>G on
plasma transcobalamin may be limited, despite its effect
on TCN transcription and transcobalamin intracellular
concentration [3]. Therefore, in our opinion, the data of
the authors are less conflicting than suggested because the
weak influence of TCN 776C>G was initially reported in
a healthy population without low serum B12 [1], drug use
[1], and renal dysfunction [2].
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Microinflammation versus
inflammation in chronic renal
failure patients
To the Editor: In their study, Pupim et al [1] show that
patients with end-stage renal failure (ESRF) in the high-
est quartile of C-reactive protein (CRP) and interleukin-6
(IL-6) before hemodialysis (HD) initiation have a signif-
icant decrease in the serum level of both markers after
12 months of HD treatment. The baseline levels for IL-6
and CRP in these subgroups were about 58 pg/mL and
62 mg/L, respectively. As the authors note, no exclusion
criteria were used for enrollment in the study. These CRP
and IL-6 serum levels are probably indicative of an infec-
tion or other cause of “real inflammation” (trauma, ma-
lignancy, etc.). In the referred study microinflammation
investigation is warranted. It is low-grade inflammation
